Login / Signup

Comparative efficacy and safety of bimekizumab in psoriatic arthritis: a systematic literature review and network meta-analysis.

Phillip J MeaseDafna D GladmanJoseph F MerolaPeter NashStacy GrieveVictor Laliman-KharaDamon WillemsVanessa TaiebAdam R PrickettLaura C Coates
Published in: Rheumatology (Oxford, England) (2024)
Bimekizumab ranked favourably among b/tsDMARDs for efficacy on joint, skin and MDA outcomes, and showed comparable safety, suggesting it may be a beneficial treatment option for patients with PsA.
Keyphrases
  • systematic review
  • prostate cancer
  • meta analyses
  • breast cancer cells
  • randomized controlled trial
  • radical prostatectomy
  • adipose tissue
  • case control
  • signaling pathway
  • cell death
  • weight loss
  • cell cycle arrest